Cystamine and cysteamine as inhibitors of transglutaminase activity .

TitleCystamine and cysteamine as inhibitors of transglutaminase activity .
Publication TypeJournal Article
Year of Publication2018
AuthorsJeitner TM, Pinto JT, Cooper AJL
JournalBiosci Rep
Volume38
Issue5
Date Published2018 10 31
ISSN1573-4935
KeywordsBiomarkers, Cystamine, Cysteamine, Cysteine, Enzyme Inhibitors, Humans, Oxidation-Reduction, Transglutaminases
Abstract

Cystamine is commonly used as a transglutaminase inhibitor. This disulphide undergoes reduction to the aminothiol compound, cysteamine. Thus, the mechanism by which cystamine inhibits transglutaminase activity could be due to either cystamine or cysteamine, which depends on the local redox environment. Cystamine inactivates transglutaminases by promoting the oxidation of two vicinal cysteine residues on the enzyme to an allosteric disulphide, whereas cysteamine acts as a competitive inhibitor for transamidation reactions catalyzed by this enzyme. The latter mechanism is likely to result in the formation of a unique biomarker, -(γ-glutamyl)cysteamine that could serve to indicate how cyst(e)amine acts to inhibit transglutaminases inside cells and the body.

DOI10.1042/BSR20180691
Alternate JournalBiosci Rep
PubMed ID30054429
PubMed Central IDPMC6123069
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065